mRNA

News

EMA finds possible link between mRNA COVID jabs and myocardi...

The EU medicines regulator has said that there is some evidence to suggest a possible link between mRNA-based vaccines for COVID-19 and rare cases of heart inflammation.

News

Sanofi doubles down on mRNA jabs with €400m-a-year R&D drive

Sanofi has just significantly increased its investment in mRNA vaccine development, earmarking €400 million ($475 million) a year in R&D funding to an effort that it hopes will deliver

News

GSK sees £20bn peak sales potential in late-stage pipeline

GlaxoSmithKline's pitch to shareholders kicked off this afternoon with an optimistic view of its late-stage pipeline – including some big sales predictions for products like its respiratory

News

Talking vaccines: Industry’s role in protecting the Gavi generation

Sanofi and Translate take first mRNA flu vaccine into clinic

Sanofi and Translate Bio have started a first clinical trial of an mRNA-based seasonal flu vaccine, adding to the COVID-19 shot already in testing as part of their three-year old collaborat

R&D

GSK on COVID and vaccine development: the pharmaphorum podca...

In the latest episode of the pharmaphorum podcast Dominic Tyer speaks with GlaxoSmithKline’s Philip Cruz about the discovery and commercialisation of new vaccines in the light of the pandem

News

Moderna seeks COVID vaccine okay as data backs 94% efficacy

Moderna has said it will file for US, European and UK emergency approval of its coronavirus vaccine straight away, after reporting updated phase 3 results for the shot.

EMA finds possible link between mRNA COVID jabs and myocardi...

Sanofi doubles down on mRNA jabs with €400m-a-year R&D drive

GSK sees £20bn peak sales potential in late-stage pipeline

Sanofi and Translate take first mRNA flu vaccine into clinic

GSK on COVID and vaccine development: the pharmaphorum podca...

Moderna seeks COVID vaccine okay as data backs 94% efficacy

TransThera's resistant biliary cancer drug cleared in China

Discover a new era of healthcare panel engagement: Grounded ...

mRNA

Editor's Picks